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TO evaluate  the  reproducibility  of  induced  sputum
analysis, and to estimate the sample size required to
obtained  reliable  results,  sputum  was  induced  by
hypertonic saline inhalation in 29 asthmatic subjects
on two different days. The whole sample method was
used for analysis, and inflammatory cells were coun-
ted on cytospin slides. Reproducibility, expressed by
intra-class  correlation  coefficients,  was  good  for
macrophages (+0.80),  neutrophils (+0.85), and eosi-
nophils  (+0.87),  but  not  for  lymphocytes  (+0.15).
Detectable  differences were 5.5%  for macrophages,
0.6% for lymphocytes, 5.2% for neutrophils, and 3.0%
for eosinophils. We conclude that analysis of induced
sputum  is  a  reproducible  method  to  study  airway
inflammation in asthma. Sample  sizes  greater than
ours give little improvement in the detectable differ-
ence of eosinophil percentages.
Key  words: Induced  sputum,  Bronchial  asthma,  Airway
inflammation
Introduction
Ever since it has been suggested that asthma could be
an  inflammatory  disease,  many  efforts  have  been
made  to  study  airway  inflammation  through  both
direct  and  indirect  methods.  The  use  of  direct
methods, such as bronchoalveolar lavage and bron-
chial biopsy,  has been  limited  mainly  by  the reluc-
tance  of  patients  to  undergo  such  invasive  proce-
dures, which may not be ethically justified for clinical
routine.
The analysis of induced sputum has been recently
introduced to study airway inflammation in asthma.1
This method is simple, well tolerated, and can thus be
easily repeated over time. As with all new methods,
reproducibility  is  of  paramount  importance. A  key
factor  affecting  reproducibility  is  saliva  contamina-
tion,  which  is  inevitably  associated  with  sputum
collection. Indeed, variable saliva contamination may
make inflammatory cell profiles difficult to recognize
and thus cause poor reliability of the results. Good
reproducibility data have been obtained when mucus
plugs  were  selected  from  the  collected  sample,2,3
whereas slightly worse data have been obtained when
the whole sample was used for analysis.4,5
In the present study, we wanted to extend previous
observations on reproducibility of sputum induction
by also assessing the importance of saliva contamina-
tion and of sample size.
Materials and methods
Subjects
We studied 29 asthmatic subjects in a stable phase of
the  disease.  The  diagnosis  of  asthma  was  made
according to internationally accepted criteria6 after
assessing  reversible  airway  obstruction  and/or non-
specific bronchial hyperresponsiveness to methacho-
line. Seventeen of 29 subjects were regularly treated
with inhaled long-acting b2-agonists and/or corticoste-
roids according to International Guidelines (Table 1).6
Protocol
On  two  different  days,  separated  by  1  week,  the
subjects  underwent  sputum  induction  with  hyper-
tonic saline. Clinical conditions and treatment were
the  same  at  the  time  of  each  evaluation.  Inhaled
glucocorticoids  and  long-acting  b2-agonists  were
withdrawn  48h  before  each  evaluation,  and  short-
acting b2-agonists were withdrawn 8h before each
evaluation. The protocol was approved by  the Uni-
versity Ethical Committee. All subjects gave informed
consent to the study procedures.
Sputum induction and bronchial
responsiveness to hypertonic saline
Sputum was induced according to the method of Pin et
al.,1 slightly modified.7 Because all subjects were in a
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administered as a pre-treatment only in subjects with
Forced  Expiratory  Volume  in  1  second  (70%  of
predicted  (n =  4).  Hypertonic  saline  solution  was
nebulized with an ultrasonic nebulizer (Sirius; Tech-
nomed, Florence, Italy) with a 2.8ml/min output, and
was inhaled for 5min periods for up to 30min. NaCl
concentration was  increased  at  intervals  of  10min
from 3% to 4% to 5%. Every 5min after the start of
nebulization, subjects were asked to rinse their mouth
and throat carefully, to discard saliva, and to try to
cough  sputum  into  a  container;  FEV1 was  then
measured. Nebulization was stopped after 30min or
when the FEV1 fell by 20% or more from baseline.
In subjects not pre-treated with b2-agonist, bron-
chial  reactivity  to  hypertonic  saline  inhalation  was
evaluated as the slope of the dose–response curve (i.e.
the ratio between the maximum FEV1 fall and the dose
of delivered hypertonic saline). The dose of delivered
hypertonic saline was calculated: dose = sum of (NaCl
concentrations ´ minutes of saline delivery).
Sputum processing
Sputum  samples  were  processed  according  to  the
method  of  Fahy  et  al.,8 slightly  modified.  After
assessing the sputum volume, sputum samples from
all 29 subjects were diluted with an equal volume of
0.1% dithiotreithol in phosphate-buffered saline (Spu-
tasol; Unipath Ltd, Basingstoke, UK). Samples were
incubated in a shaking bath at 37°C for 20min, then
aspirated in and out of a pipette to further dissolve
mucus  plugs.  An  aliquot  (150ml)  of  the  sputum
sample was cytocentrifuged (Cytospin; Shandon Sci-
entific,  Sewickley,  PA,  USA)  and  stained  with  Diff-
Quik  (Baxter  Scientific  Products,  Miami,  FL,  USA).
Two investigators, blinded to the subject’s code, each
first counted at least 500 cells on each sputum slide so
as  to  obtain  the  squamous  cell  percentage  as  an
indicator of  saliva contamination. At least 300  non-
squamous  cells  were  then  counted  on  satisfactory
slides. Cytospin slides with an amount of squamous
cells such that 300 non-squamous cells could not be
counted  were  considered  unsatisfactory  and  dis-
carded. Slides were then given a score ranging from 0
(cells so disrupted that cannot be recognized) to 3
(cells  well  recognizable, cell  membranes  intact, no
cell  clusters).  A  slide  score  ‡ 1  was  considered
satisfactory. All cell percentages were averaged to give
the final values reported here. Macrophage, lympho-
cyte,  neutrophil,  eosinophil  percentages were  thus
expressed as a percent of the total inflammatory cells,
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Table 1. Clinical characteristics of asthmatic subjects
Patient Sex Age (years) Asthma degree Treatment* FEV1**
Test 1 Test 2
1 Female 16 Mild persistent 1000 + b2 103 100
2 Female 44 Moderate persistent 1500 + b2 90 80
3 Male 22 Intermittent No 83 96
4 Female 20 Moderate persistent 500 98 104
5 Male 17 Moderate persistent 500 113 118
6 Male 35 Moderate persistent 1000 + b2 92 83
7 Male 27 Intermittent No 95 93
8 Female 31 Intermittent No 87 90
9 Female 54 Intermittent No 92 79
10 Female 40 Intermittent No 83 80
11 Female 67 Mild persistent 500 107 105
12 Male 20 Intermittent No 83 87
13 Female 57 Mild persistent No 85 77
14 Male 23 Intermittent No 109 109
15 Female 42 Intermittent No 90 89
16 Female 31 Intermittent No 103 106
17 Male 51 Moderate persistent 1000 + b2 97 100
18 Male 68 Moderate persistent 1000 84 86
19 Male 45 Mild persistent 500 78 73
20 Male 31 Moderate persistent No 85 88
21 Female 58 Severe 1500 + b2 70 66
22 Male 64 Severe 1000 + b2 + T 57 57
23 Female 29 Moderate persistent 1500 + b2 + T 69 80
24 Male 32 Moderate persistent 1500 + b2 72 81
25 Female 64 Mild persistent No 91 82
26 Male 42 Moderate persistent 2000 + b2 + T 86 86
27 Female 43 Moderate persistent 2000 + b2 + T 86 113
28 Female 59 Severe 1750 + b2 + T 48 58
29 Female 32 Moderate persistent 1000 + T 91 88
*Daily beclomethasone dipropionate dose (mg). b2, long-acting b2-agonist; T: theophylline.
**FEV1 is expressed as the percent of the predicted value.excluding  squamous  cells.  The  remainder  of  the
sputum sample was centrifuged at 450 ´ g for 10min.
The cell  pellets were resuspended in  1ml  of  phos-
phate-buffered  saline  for  total  cell  counts  with  the
T¨ urk staining and cell viability assessment by Trypan
blue exclusion in a hemocytometer. Samples with cell
viability <70% were discarded.
Statistical analysis
Cell percentages, sputum volumes, and the slope of
the dose–response curve to hypertonic saline inhala-
tion are expressed as the median and range. FEV1 is
expressed as the mean ± standard deviation. Wilcox-
on’s signed rank test was used to compare sputum
cell percentages and the slope of the dose–response
curve to hypertonic saline inhalation obtained in the
two  different  sputum  inductions. The  paired  t-test
was  used  to  compare  the  FEV1 values  measured
before each sputum induction. Intra-class correlation
coefficients  (RI)  were  calculated  to  evaluate  the
concordance of sputum cell percentages and of the
slope  of  the  dose–response  curve  to  hypertonic
saline inhalation obtained in  the two different  spu-
tum  inductions,  and  RI  values  ‡   +0.70  were  con-
sidered  satisfactory.9 To  test  whether  saliva  con-
tamination  affects  reproducibility,  RI  values  were
calculated for sub-groups selected on the basis of the
highest squamous cell percentage counted on each
pair of  slides. Variability  between two  observations
was expressed by means of a plot of the differences
between  the  values  of  each  pair  of  observations
against the mean value of the same pair of observa-
tions.10 Sample  sizes  and  detectable  differences
were  evaluated  according  to  the  method  used  by
Ward et al.11
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Table 2. Reproducibility of inflammatory cell percentages in induced sputum of asthmatic subjects
Macrophages Lymphocytes Neutrophils Eosinophils Squamous
Day 1 (%) 42.7 (10.3–86.7) 0.3 (0–3.4) 33.7 (11.9–87.6) 4.5 (0–66.6) 22.4 (4–79)
Day 2 (%) 41.2 (8.1–94.9) 0.6 (0–3.9) 35.3 (3.4–91.9) 6.9 (0–58) 20.9 (1–79.3)
p 0.79 0.60 0.56 0.11 0.87
RI + 0.80 + 0.15 + 0.85 + 0.87 + 0.05
Inflammatory cells are expressed as the percentage of non-squamous cells. RI, intra-class correlation coefficient.
FIG. 1. Plots  of  differences  between sputum  induction procedures  (test  1 –  test  2) versus  mean  values  for  sputum  cell
percentages.  Open  circles,  untreated  patients;  closed  circles,  treated  patients.  The  hatched  area  includes  the  mean  of
differences between test 1 and test 2 ± two standard deviations of the mean.Results
Cell counts
All slides were such that at least 300 cells could be
counted. Slide scores were ‡ 1 and viability was ‡ 70%
for all samples. There were no significant differences
in cell percentages from sputum samples obtained on
the two different days. RI values were satisfactory for
macrophages, neutrophils, and eosinophils, but not
for  lymphocytes  (Table  2).  RI  values  for  total  cell
counts  were  low. The  plots  showing  variability  of
differential cell counts are reported in Fig. 1.
Saliva contamination
Saliva contamination was variable, with squamous cell
percentages  reaching  up  to  almost  80%  (Table  2).
However, when slides with progressively lower squa-
mous cell contamination were selected, RI values for
inflammatory cells did not increase except for macro-
phages,  which  showed an  isolated higher  RI  value
when only samples with <20% squamous cells where
considered (Table 3).
Bronchial responsiveness to hypertonic saline
There was no significant difference in the slope of the
dose–response  curve  between  the  two  different
hypertonic saline inhalations [0.232 (0–3.133) versus
0.253  (0.025–2.733)],  as  well  as  in  baseline  FEV1
(88.6 ± 2.5% versus 88.2 ± 2.6%). The RI value for the
slope  of  the  dose–response  curve  was  satisfactory
(+0.81).  The  FEV1 decrease after  hypertonic  saline
was 20% (0–47) on day 1 and 20% (2–41) on day 2.
No relationship was observed between baseline FEV1
and the FEV1 decrease after hypertonic saline. Bron-
choconstriction was promptly relieved by inhalation
of a b2-agonist.
Sample size calculations
An estimate of the sample sizes required for a range of
specified detectable differences in sputum  cell  per-
centages for paired observations was calculated. The
standard  deviation  of  the  differences,  required  to
calculate  the  sample  sizes,  was  10.6%  for  macro-
phages, 1.2% for lymphocytes, 9.9% for neutrophils,
and 5.7% for eosinophils. Thus, at p = 0.05 and 80%
power, a sample size of 29 subjects yields a detectable
difference of 5.5% for macrophages, 0.6% for lympho-
cytes, 5.2% for neutrophils, and 3.0% for eosinophils.
Figure 2 shows the plot of an estimate of the sample
sizes calculated for eosinophils.
Discussion
The  present  study  confirms  that  the  analysis  of
induced sputum is a reproducible means to evaluate
airway inflammation in asthma. Reproducibility was
good  for  most  cell  types,  with  the  exception  of
lymphocytes. Also, the inhalation of hypertonic saline
to  induce  sputum  production  is  a  reproducible
method  to  assess  non-specific  bronchial  hyper-
responsiveness.
The recent introduction of the analysis of induced
sputum in the evaluation of airway inflammation has
raised  great  interest  because  it  is  simple  and  well
tolerated.  However,  there  are  some  controversies
about  the  method to  be  used  for  sputum  analysis,
and about its reproducibility. Several papers dealing
with  reproducibility  have  recently  been  published,
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Table 3. Intra-class correlation coefficients for sputum inflammatory cells, calculated for sub-groups selected on the basis of
different levels of squamous cell contamination
Squamous cells (%) n Intra-class correlation coefficients
Macrophages Lymphocytes Neutrophils Eosinophils
<80 29 + 0.80 + 0.15 + 0.85 + 0.87
<70 27 + 0.73 + 0.07 + 0.83 + 0.87
<60 26 + 0.70 + 0.05 + 0.76 + 0.87
<50 26 + 0.70 + 0.05 + 0.76 + 0.87
<40 22 + 0.69 – 0.04 + 0.64 + 0.85
<30 16 + 0.73 + 0.05 + 0.76 + 0.86
<20 9 + 0.91 – 0.05 + 0.67 + 0.69
n, number of patients.
FIG.  2.  Plot  of  detectable  differences  versus  sample  size
required, based on 80% power  and p = 0.05, for  sputum
eosinophil percentages.reporting  data  obtained  both  in  children12 and  in
adults.2–4 The study in children dealt with reproduci-
bility of the ‘whole sample’ method, and showed good
sputum eosinophil reproducibility.12 Among the stud-
ies  in  adults,  two  articles  dealt  with  intra-subject
reproducibility  of  the  ‘plugs’  method2,3 and  one
article dealt with intra-subject reproducibility of the
‘whole sample’ method.4 For the ‘plugs’ method, both
papers found good intra-class correlation coefficients
for macrophage, neutrophil, and eosinophil percen-
tages,  whereas  the  paper  on  the  ‘whole  sample’
method found  good results  for  eosinophil and lym-
phocyte  percentages.4 Using  the  ‘whole  sample’
method, we found good intra-class correlation coeffi-
cients  for  macrophage,  neutrophil,  and  eosinophil
percentages. These differences might be explained by
the  different  amounts  of  saliva  contamination. Our
data are expressed as the median and range, but when
the mean ± standard deviation were calculated the
values for squamous cell percentages in the present
study (day 1, 25.1 ± 16.2%; day 2, 23.7 ± 16.9%) were
lower than those reported by the study on the ‘whole
sample’ method.4 Despite the expression of results in
terms of percentages of inflammatory cells eliminat-
ing the variability due to sample dilution by saliva, the
presence of  a high  number  of  squamous  cells  may
make  inflammatory  cells  hard  to  recognize  on  the
slide. This fact confirms that low saliva contamination
is  essential  to  obtain  reliable  results  in  sputum
analysis. Ward et al.13 have recently shown that excess
squamous  cell  contamination negatively  affects  the
accuracy  of  sputum  differential  cell  counts.  In  the
present study, the step-by-step elimination of sputum
samples  with  progressively  higher  squamous  cell
contamination does not increase RI values for most
cell types. This may be due to the fact that only seven
out of  29  subjects  had sputum  samples with  squa-
mous cells ‡ 40%, and thus their relative weight on
reproducibility was low. Only macrophage reproduci-
bility increased when samples with very low (<20%)
squamous cell contamination were considered. This
finding supports the hypothesis that excess squamous
cell  contamination makes macrophages hard to dis-
tinguish.13 Conversely, the low RI values obtained for
the  other  inflammatory  cells  when  squamous  cells
were <20% may be explained by the small number of
samples (n = 9) included in statistical analysis. The
good RI values obtained for inflammatory cells at the
different levels  of saliva contamination may also be
explained by the fulfillment  of criteria used for the
selection of satisfactory slides.
Three more articles dealt with intrasubject sputum
reproducibility using the ‘whole sample’ method. The
paper by Gershman et al.14 expressed reproducibility
results  in  terms  of  the  variation  coefficient,  and
cannot  therefore  be  compared  with  the  present
results. Fahy et al. found sputum eosinophil reproduc-
ibility  slightly  below  acceptable  values.5 However,
this  was  a  multicenter  study,  which  might  partly
explain the results. For the same reason, it is difficult
to compare that study with our present one. Thomas
et al.15 found very poor sputum cell count reproduci-
bility,  since  the  only  RI  value  they  provide  is  the
highest  that  they  obtained  (0.44  for  lymphocytes).
Thus,  the  only  paper  dealing  with ‘whole  sample’
reproducibility  that  can  be  compared  with  the
present one is that by in’t Veen et al.,4 who found
slightly worse results than we did, possibly because of
the greater squamous cell contamination. Since there
are discrepancies on results of sputum reproducibility
studies,  especially  for  the  whole  sample  method,
ranging from very poor15 to very good, we thought
that adding one further report on this issue  would
help assess the reliability and usefulness of induced
sputum analysis.
A  crucial  issue  for  reproducibility  is  the  time
interval between inductions. It has been shown that
the  induction  procedure itself  changes  the  sputum
composition, detectable within 24h.16,17Thus, such a
short  time  interval  between  two  inductions  is  not
recommended. On the contrary, a long time interval
may affect reproducibility because asthma is variable
per se. This might partly explain the poor reproduci-
bility found by Thomas et al., who repeated sputum
inductions 2 weeks apart.15Although there is no clear
demonstration  of  the  best  time  interval  between
inductions, we thought that 1 week was good enough
to  reduce  factors  negatively  affecting  sputum
reproducibility.
The reproducibility of total cell counts was poor in
all  groups,  as  already  shown  by  the  studies  on
reproducibility of the ‘plugs’ method. This may be due
to the fact that total cell  counts are expressed per
volume unit. Sputum volume may vary over a wide
range because of variable saliva contamination, and
this  is  especially  true  for  the  ‘whole  sample’
method.
All patients were studied in a stable phase of the
disease, but since it has been shown that the degree
of  the  FEV1 decrease  after  hypertonic  saline  is
significantly  correlated  with  the  baseline  FEV1
value,18 patients  with  FEV1 <70%  were  pre-treated
with inhaled b2-agonist. However, hypertonic saline
did  not  cause  any  major  adverse event  in  subjects
who experienced bronchoconstriction. On  average,
the FEV1 decrease from baseline was of a mild degree,
and  this  was  due,  at  least  in  part,  to  the  close
monitoring  of  pulmonary  function  during  sputum
induction and to the prompt cessation of hypertonic
saline inhalation as soon as the FEV1 value fell below
acceptable limits.
The calculations of sample sizes show that sample
sizes greater than ours in the present study give little
improvement  in  the  detectable  differences  for  all
cell  percentages.  For  example,  by  doubling  the
sample  size,  the  detectable  difference  would  be
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for  neutrophils,  and  2.1%  for  eosinophils.  When
planning a study design, we must keep in mind what
detectable  difference  is  reasonable  for  the  specific
results  one  is  looking  for.  Since  in  most  cases the
differences observed for eosinophils (e.g. eosinophil
decrease  after  steroid  treatment,  or  eosinophil
increase during asthma exacerbation)19,20 are much
greater than 3%, which is the detectable difference
we found in the present study, there is no need to
study a larger number of subjects to obtain reliable
results.
The analysis of broncho-alveolar lavage (BAL) fluid
has provided important results in the study of airway
inflammation in asthma, and there are currently no
doubts about the reliability of such results. Data on
sputum reliability are similar to data on BAL reliability.
In a paper by Ward et al.,11 the detectable difference
for eosinophils in BAL fluid was about 0.5%, with a
mean value of about 2% and a standard deviation of
2–2.5%, and this was considered as acceptable. Again,
our data are expressed as the median and range, but
when the mean ± standard deviation were calculated
the values for eosinophil percentages in the present
study  were  14.6  ±  17.9%. That  is,  our  detectable
difference  is  about  one-fifth  of  the  observed mean
value, whereas the detectable difference for eosino-
phils in BAL fluid was about one-quarter of the mean
value obtained by Ward et al.
Although  studies  on  reproducibility  of  induced
sputum  analysis  have  already  been  published,  we
believe that confirming the validity of this method is
useful. In conclusion, the present study confirms that
the  analysis  of  induced  sputum  is  a  reproducible
method to study airway inflammatory cells when an
adequate  sample  size  is  considered.  In  particular,
when  saliva  contamination  is  kept  reasonably  low,
reproducibility  of  the  ‘whole  sample’  method  is
similar to that of the ‘plugs’ method.
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